Nevertheless, SM-164 enhanced APO2L/TRAIL-mediated cell death induction in HCC cells from 11 out of 12 patients, including APO2L/TRAIL-sensitive cells from 5 patients and APO2L/TRAIL-resistant cells from 6 patients. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.